Active, Not Recruiting
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations
NCT05498272
- Conditions
- BRCA1 Mutation, BRCA2 Mutation, Genital Diseases, +12 more
- Locations
-
- University of California San Diego - Moores Cancer Center La Jolla, California, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Columbia University Irving Medical Center New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States